Skip to content

Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be Replaced by Whipple Over the Splenic Artery: A Before and After Study

Most Total Pancreatectomies for Ductal Adenocarcinoma Can Be Replaced by Whipple Over the Splenic Artery: A Before and After Study

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06119776
Enrollment
70
Registered
2023-11-07
Start date
2020-05-20
Completion date
2025-05-20
Last updated
2023-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ductal Adenocarcinoma of the Pancreas

Keywords

Ductal Adenocarcinoma, Pancreatectomies, Whipple

Brief summary

Recently, more and more total pancreatectomy (TP) has been performed for pancreatic ductal cell adenocarcinoma (PDCA) which abuts or involves both gastroduodenal and splenic arteries. Warshaw's procedure (spleen-preserving distal pancreatectomy with excision of splenic vessels) has been safely performed for years. Likewise, both pancreatic tail and spleen can be preserved after excision of splenic vessels for leftward extension of pancreatic parenchyma transaction line during Whipple (WOTSA). In that case, TP can be replaced by WOTSA. This uncontrolled before and after study assesses the safety and efficacy of a new technique Whipple over the splenic artery (WOTSA) as a treatment for PDAC which traditionally requires total pancreatectomy (TP).

Detailed description

Recently, more and more total pancreatectomy (TP) has been performed for pancreatic ductal cell adenocarcinoma (PDCA) which abuts or involves both gastroduodenal and splenic arteries. Warshaw's procedure (spleen-preserving distal pancreatectomy with excision of splenic vessels) has been safely performed for years. Likewise, both pancreatic tail and spleen can be preserved after excision of splenic vessels for leftward extension of pancreatic parenchyma transaction line during Whipple (WOTSA). In that case, TP can be replaced by WOTSA. This uncontrolled before and after study assesses the safety and efficacy of a new technique Whipple over the splenic artery (WOTSA) as a treatment for PDAC which traditionally requires total pancreatectomy (TP). Methods: The study group comprised 40 consecutive patients who underwent WOTSA for PDAC. Their clinicopathological characteristics and survival were compared with those of a historical control group comprising 30 consecutive patients who underwent TP between.

Interventions

PROCEDUREWhipple over the splenic artery

Treatment for pancreatic ductal cell adenocarcinoma

Treatment for pancreatic ductal cell adenocarcinoma

Sponsors

National Taiwan University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* pancreatic ductal cell adenocarcinoma (PDCA) patients

Exclusion criteria

* Patient undergoing palliative pancreatectomy, other malignancies with distant metastases * Vulnerable groups

Design outcomes

Primary

MeasureTime frameDescription
Clinicopathological characteristicsbeforeMeasurement of the remnant pancreatic volume

Secondary

MeasureTime frameDescription
Postoperative chemotherapy and follow-up1 month after the operationMeasurement of the remnant pancreatic volume and physiological parameters

Other

MeasureTime frameDescription
Number of participants with treatment-related adverse events as assessed by CTCAE v4.01 day before the operationMeasurement of the physiological parameters

Countries

Taiwan

Contacts

Primary ContactTing-Chun Kuo
tinakuo1204@gmail.com+88623123456

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026